Eikon Therapeutics, Inc.

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Regulation FD Disclosure

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

Certification of approval for listing and registration on a national securities exchange

Notice of Effectiveness

Amended Initial Registration Statement

Registration of Securities on Exchange

Registration (IPO) statement under Securities Act of 1933

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)

<ITEMS>06b

06b

06b

06b

Svennilson Peter; Kutzkey Tim; Column Group IV-A, LP; Column Group IV, LP; Column Group Opportunity III GP, LP; Column Group IV GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC

Francisco Ma. Fatima

Klobuchar Michael A

Baynes Roy D.

Thorner Benjamin Bruno

Bowie Alfred Lloyd Jr.

PERLMUTTER ROGER M

FRAZIER KENNETH C

Huffines Robert Luther

PERLMUTTER ROGER M